Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Taiwan President Lai Oversees Coastal Strike Drills in Han Kuang War Games 
US Expands Social Media Vetting to Foreign Journalists Seeking Visas 
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks 
Germany Warns of Daily Hybrid Warfare Threats 
US Supreme Court Lets $655.5 Million Judgment Against Palestinian Authorities Stand During Appeal 
US-Backed Venezuela Government, Opposition Talks Begin 
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
Senate Majority Leader John Thune Moves to Advance Crypto Clarity Act 
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak 
US Embassies Urge Americans to Leave Middle East as Iran Tensions Escalate 
Trump Faces Tough Choices as Iran War Drags On 
Russia Intensifies Drone and Bomb Attacks on Ukraine’s Zaporizhzhia, Deepening Civilian Fear 
FAA Proposes Inspections for Boeing 737 MAX Passenger Seats Over Installation Concern 
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent 
US Customs Inspects China-Linked Factories in Vietnam Amid Trade Compliance Review 
India Plans Tax Reforms to Boost Foreign Investment and Manufacturing 
U.S. Health Secretary Robert F. Kennedy Jr. told lawmakers this week that he is open to sharing details about David Geier’s contract with the Department of Health and Human Services (HHS), signaling growing scrutiny over the controversial appointment. During a Senate Finance Committee hearing, Kennedy stated that the contract could be provided to senators before the end of the week, offering what may become the first clear explanation of Geier’s responsibilities within the agency.
David Geier, known for his long-standing anti-vaccine activism, is currently working as a contractor tied to the Centers for Disease Control and Prevention (CDC). According to federal records, he is listed as a senior data analyst within the HHS system. His involvement has raised concerns among lawmakers and public health experts, particularly given his history of promoting debunked claims linking vaccines to autism.
Senator Ben Ray Luján of New Mexico pressed Kennedy on whether the administration would also release the protocols guiding Geier’s work. Kennedy responded that such protocols are not yet in place but promised they would be shared once the vaccine safety review is completed. Kennedy has previously indicated that Geier is leading a review of CDC vaccine data, a move that has sparked debate due to Geier’s controversial background.
Geier’s past actions have added to the concern. He was previously fined in Maryland for practicing medicine without a license and for administering unsafe treatments to children with autism. Critics argue that his involvement in federal health initiatives could undermine public trust in vaccine safety.
The situation highlights ongoing tensions around vaccine policy, public health transparency, and the role of individuals with disputed scientific views in government positions. As pressure builds, the release of Geier’s HHS contract could play a key role in shaping public and political response to the administration’s handling of vaccine-related issues.
